PubMed (MeSH Keyword) for id: 23676225

Year	Number of Results
1993	1
1995	1
1997	1
1998	3
2000	1
2001	1
2002	1
2005	1
2024	0

1

Influence of hormone therapy on the cardiovascular responses to stress of postmenopausal women.

Matthews KA, Owens JF, Salomon K, Harris KF, Berga SL. Matthews KA, et al. Biol Psychol. 2005 Apr;69(1):39-56. doi: 10.1016/j.biopsycho.2004.11.004. Epub 2005 Jan 4. Biol Psychol. 2005. PMID: 15740824 Clinical Trial.

2

Evaluation of high-dose estrogen and high-dose estrogen plus methyltestosterone treatment on cognitive task performance in postmenopausal women.

Wisniewski AB, Nguyen TT, Dobs AS. Wisniewski AB, et al. Horm Res. 2002;58(3):150-5. doi: 10.1159/000064491. Horm Res. 2002. PMID: 12218381 Clinical Trial.

3

Low-dosage esterified estrogens opposed by progestin at 6-month intervals.

Ettinger B, Pressman A, Van Gessel A. Ettinger B, et al. Obstet Gynecol. 2001 Aug;98(2):205-11. doi: 10.1016/s0029-7844(01)01419-3. Obstet Gynecol. 2001. PMID: 11506834 Clinical Trial.

4

Esterified estrogen therapy in postmenopausal women. Relationships of bone marker changes and plasma estradiol to BMD changes: a two-year study.

Watts NB, Nolan JC, Brennan JJ, Yang HM; ESTRATAB/Osteoporosis Study Group. Watts NB, et al. Menopause. 2000 Nov-Dec;7(6):375-82. doi: 10.1097/00042192-200011000-00002. Menopause. 2000. PMID: 11127759 Clinical Trial.

5

Acceptability of a substitution of estrogen replacement therapy to women enrolled in a health maintenance organization.

Gardner J, Scholes D, Baluch W, Krauss R. Gardner J, et al. J Womens Health. 1998 Oct;7(8):1027-31. doi: 10.1089/jwh.1998.7.1027. J Womens Health. 1998. PMID: 9812299

6

Low-dose estrogen for bone loss.

[No authors listed] [No authors listed] Harv Womens Health Watch. 1998 May;5(9):7. Harv Womens Health Watch. 1998. PMID: 9589156 No abstract available.

7

Low-dose estrogen.

[No authors listed] [No authors listed] Health News. 1998 Apr 20;4(5):7. Health News. 1998. PMID: 9563304 No abstract available.

8

Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study Group.

Genant HK, Lucas J, Weiss S, Akin M, Emkey R, McNaney-Flint H, Downs R, Mortola J, Watts N, Yang HM, Banav N, Brennan JJ, Nolan JC. Genant HK, et al. Arch Intern Med. 1997 Dec 8-22;157(22):2609-15. doi: 10.1001/archinte.157.22.2609. Arch Intern Med. 1997. PMID: 9531230 Clinical Trial.

9

A comparison of esterified estrogens with and without methyltestosterone: effects on endometrial histology and serum lipoproteins in postmenopausal women.

Hickok LR, Toomey C, Speroff L. Hickok LR, et al. Obstet Gynecol. 1993 Dec;82(6):919-24. Obstet Gynecol. 1993. PMID: 8233265 Clinical Trial.

10

Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause.

Watts NB, Notelovitz M, Timmons MC, Addison WA, Wiita B, Downey LJ. Watts NB, et al. Obstet Gynecol. 1995 Apr;85(4):529-37. doi: 10.1016/0029-7844(94)00448-m. Obstet Gynecol. 1995. PMID: 7898828 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year